Finance

Lists
RPGLIFE:NSE
RPG Life Sciences Ltd
₹2,696.00
-3.12%
(-86.70) 1D
Sep 11, 3:30:01 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for RPGLIFE...
Open
₹2,794.30
High
₹2,794.30
Low
₹2,680.00
Mkt. cap
44.59B
Avg. vol.
0.00
Volume
17.82K
Dividend
0.89%
Quarterly dividend
₹6.00
Ex-dividend date
Jul 9, 2026
P/E ratio
37.27
52-wk high
₹3,082.00
52-wk low
₹1,733.00
EPS
₹72.34
Shares outstanding
16.54M
No. of employees
1K
Open
₹2,794.30
High
₹2,794.30
Low
₹2,680.00
Mkt. cap
44.59B
Avg. vol.
0.00
Volume
17.82K
Dividend
0.89%
Quarterly dividend
₹6.00
Ex-dividend date
Jul 9, 2026
P/E ratio
37.27
52-wk high
₹3,082.00
52-wk low
₹1,733.00
EPS
₹72.34
Shares outstanding
16.54M
No. of employees
1K
Profile
RPG Life Sciences is an Indian pharmaceutical company. Formerly known as Searle Ltd, RPG Life Sciences is part of RPG Enterprises. It has its corporate office in RPG House in Worli, Mumbai. Its three major activities are the manufacturing and marketing of bulk drugs, also known as active pharmaceutical ingredients; pharmaceutical formulation; and fermentation and biotechnology. RPGLS is present in the domestic as well as the international market. It exports its products primarily to Europe, Latin America, Australia and South East Asian countries. Wikipedia
About RPG Life Sciences Ltd
CEO-
Employees1.37K
Founded1993
Headquarters-
SectorPharmaceutical industry
Websiterpglifesciences.com
Last report
Jul 28, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
1.96B / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.82B
1.80B
1.77B
1.96B
Cost of goods sold
665.80M
649.00M
661.00M
681.50M
Cost of revenue
665.80M
649.00M
661.00M
681.50M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
361.60M
353.20M
570.90M
377.60M
Operating expense
812.90M
807.50M
835.00M
901.50M
Total operating expenses
1.48B
1.46B
1.50B
1.58B
Operating income
338.10M
343.80M
273.30M
373.90M
Other non operating income
45.40M
34.10M
-101.90M
47.00M
EBT including unusual items
494.50M
291.20M
402.00M
414.60M
EBT excluding unusual items
382.30M
375.40M
277.30M
414.60M
Income tax expense
126.00M
69.90M
103.00M
107.00M
Effective tax rate
25.48%
24.00%
25.62%
25.81%
Other operating expenses
399.10M
400.50M
206.70M
464.90M
Net income
368.50M
221.30M
299.00M
307.60M
Net profit margin
20.28%
12.29%
16.90%
15.72%
Earnings per share
-
-
-
-
Interest and investment income
-
-
96.70M
-
Interest expense
-1.20M
-2.50M
-3.90M
-6.30M
Net interest expenses
-1.20M
-2.50M
92.80M
-6.30M
Depreciation and amortization charges
52.20M
53.80M
57.40M
59.00M
EBITDA
389.90M
395.75M
325.80M
426.40M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps